RSV Vaccine For ages 60 and over

• Adults aged 60 years and over
• Adults aged 50 years with underlying diseases such as diabetes, heart disease, lung disease
• The efficacy of the vaccine against lower respiratory tract diseases is 94.6%.

Note

1. The above price includes doctor’s fee and hospital service fee.
2. The above price does not include other treatment costs in case the service recipient has a chronic disease.
3. We reserve the right to change the service recipient or refund in all cases.
4. Starting from today – 31 December 2025

Today – 31 December 2025